BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamidullah, Changkija B, Konwar R. Role of interleukin-10 in breast cancer. Breast Cancer Res Treat 2012;133:11-21. [PMID: 22057973 DOI: 10.1007/s10549-011-1855-x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Han X, Bi L, Wu Y, Yan J, Wu X, Zheng R, Sun Y, Zhang H, Wang Z, Wang Y, Zhang H. Genetically engineered exosomes for targetedly preventing premetastatic niche formation and suppressing postoperative melanoma lung metastasis. Nano Today 2022;46:101597. [DOI: 10.1016/j.nantod.2022.101597] [Reference Citation Analysis]
2 Aguilar-cazares D, Chavez-dominguez R, Marroquin-muciño M, Perez-medina M, Benito-lopez JJ, Camarena A, Rumbo-nava U, Lopez-gonzalez JS. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. Front Endocrinol 2022;13:929572. [DOI: 10.3389/fendo.2022.929572] [Reference Citation Analysis]
3 Fontvieille E, His M, Biessy C, Navionis AS, Torres-Mejía G, Ángeles-Llerenas A, Alvarado-Cabrero I, Sánchez GI, Navarro E, Cortes YR, Porras C, Rodriguez AC, Garmendia ML, Soto JL, Moyano L, Porter PL, Lin MG, Guenthoer J, Romieu I, Rinaldi S; PRECAMA team. Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study. BMC Cancer 2022;22:877. [PMID: 35948877 DOI: 10.1186/s12885-022-09975-6] [Reference Citation Analysis]
4 Espinosa Gonzalez M, Volk-Draper L, Bhattarai N, Wilber A, Ran S. Th2 cytokines IL-4, IL-13, and IL-10 promote differentiation of pro-lymphatic progenitors derived from bone marrow myeloid precursors. Stem Cells Dev 2022. [PMID: 35442077 DOI: 10.1089/scd.2022.0004] [Reference Citation Analysis]
5 Naderi M, Kordestani H, Sahebi Z, Khedmati Zare V, Amani-Shalamzari S, Kaviani M, Wiskemann J, Molanouri Shamsi M. Serum and gene expression profile of cytokines following combination of yoga training and vitamin D supplementation in breast cancer survivors: a randomized controlled trial. BMC Womens Health 2022;22:90. [PMID: 35331230 DOI: 10.1186/s12905-022-01671-8] [Reference Citation Analysis]
6 Huo J, Fu L, Jin M, Li Z, Zhang M. IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4. Invest New Drugs. [DOI: 10.1007/s10637-022-01224-8] [Reference Citation Analysis]
7 Pratap PD, Raza ST, Zaidi G, Kunwar S, Ahmad S, Charles MR, Eba A, Rajput M. Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study. Glob Med Genet. [DOI: 10.1055/s-0042-1743262] [Reference Citation Analysis]
8 Ringquist R, Ghoshal D, Jain R, Roy K. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models. Adv Drug Deliv Rev 2021;179:114003. [PMID: 34653533 DOI: 10.1016/j.addr.2021.114003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Cuellar-Gómez H, Ocharán-Hernández ME, Calzada-Mendoza CC, Comoto-Santacruz DA. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00074-8. [PMID: 34312118 DOI: 10.1016/j.rgmxen.2021.07.001] [Reference Citation Analysis]
10 Cuellar-Gómez H, Ocharán-Hernández ME, Calzada-Mendoza CC, Comoto-Santacruz DA. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Rev Gastroenterol Mex 2021:S0375-0906(21)00035-5. [PMID: 34210555 DOI: 10.1016/j.rgmx.2020.12.002] [Reference Citation Analysis]
11 Liu Z, Hu S, Yun Z, Hu W, Zhang S, Luo D. Using dynamic cell communication improves treatment strategies of breast cancer. Cancer Cell Int 2021;21:275. [PMID: 34034721 DOI: 10.1186/s12935-021-01979-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Jin J, Li Y, Zhao Q, Chen Y, Fu S, Wu J. Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression. Cell Commun Signal 2021;19:50. [PMID: 33957948 DOI: 10.1186/s12964-021-00705-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Chen D, Huang L, Zhou H, Zhang Y. Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells. Front Immunol 2021;12:615089. [PMID: 33717103 DOI: 10.3389/fimmu.2021.615089] [Reference Citation Analysis]
14 Chang CM, Lam HYP, Hsu HJ, Jiang SJ. Interleukin-10: A double-edged sword in breast cancer. Tzu Chi Med J 2021;33:203-11. [PMID: 34386356 DOI: 10.4103/tcmj.tcmj_162_20] [Reference Citation Analysis]
15 Alves MT, Simões R, Pestana RMC, de Oliveira AN, Oliveira HHM, Soares CE, Sabino AP, Silva LM, Gomes KB. Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study. Immunol Invest 2021;:1-16. [PMID: 33557640 DOI: 10.1080/08820139.2021.1882486] [Reference Citation Analysis]
16 Montironi C, Muñoz-Pinedo C, Eldering E. Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions. Cancers (Basel) 2021;13:284. [PMID: 33466674 DOI: 10.3390/cancers13020284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Orujova IN, Azizova GI, Gafarov IA, Orujov AH. Study of correlation between biochemical indicators and radiological diagnostic parameters of breast cancer. Klin Lab Diagn 2020;65:738-43. [PMID: 33373504 DOI: 10.18821/0869-2084-2020-65-12-738-743] [Reference Citation Analysis]
18 Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. Int Rev Immunol 2021;40:197-216. [PMID: 33258393 DOI: 10.1080/08830185.2020.1845670] [Reference Citation Analysis]
19 Datta A, Tuz Zahora F, Abdul Aziz M, Sarowar Uddin M, Ferdous M, Shalahuddin Millat M, Shahid Sarwar M, Abdul Barek M, Jafrin S, Nahar S, Safiqul Islam M. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. International Immunopharmacology 2020;89:107091. [DOI: 10.1016/j.intimp.2020.107091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Leon E, Ranganathan R, Savoldo B. Adoptive T cell therapy: Boosting the immune system to fight cancer. Semin Immunol 2020;49:101437. [PMID: 33262066 DOI: 10.1016/j.smim.2020.101437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Breeta RDIE, Grace VMB, Wilson DD. Methyl Palmitate-A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti-cancer effects on hepatocellular carcinoma cells. Basic Clin Pharmacol Toxicol 2021;128:366-78. [PMID: 33128309 DOI: 10.1111/bcpt.13525] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 L D Santos L, D D Custódio I, Silva ATF, C C Ferreira I, C Marinho E, C Caixeta D, V Souza A, R Teixeira R, Araújo TG, Shivappa N, R Hébert J, Paiva CE, S Espíndola F, Goulart LR, C P Maia Y. Overweight Women with Breast Cancer on Chemotherapy Have More Unfavorable Inflammatory and Oxidative Stress Profiles. Nutrients 2020;12:E3303. [PMID: 33126617 DOI: 10.3390/nu12113303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Giúdice AD, Pagura L, Capitani MC, Mainetti LE, Scharovsky OG, Di Masso RJ, Rico MJ, Rozados VR. Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition. Future Sci OA 2020;6:FSO589. [PMID: 33312693 DOI: 10.2144/fsoa-2019-0108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Valdés-Ferrada J, Muñoz-Durango N, Pérez-Sepulveda A, Muñiz S, Coronado-Arrázola I, Acevedo F, Soto JA, Bueno SM, Sánchez C, Kalergis AM. Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients. Front Immunol 2020;11:1413. [PMID: 32733470 DOI: 10.3389/fimmu.2020.01413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Invernizzi M, Lopez G, Michelotti A, Venetis K, Sajjadi E, De Mattos-Arruda L, Ghidini M, Runza L, de Sire A, Boldorini R, Fusco N. Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema. Front Oncol 2020;10:422. [PMID: 32300557 DOI: 10.3389/fonc.2020.00422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Bujak JK, Szopa IM, Pingwara R, Kruczyk O, Krzemińska N, Mucha J, Majchrzak-Kuligowska K. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors. Int J Mol Sci 2020;21:E2292. [PMID: 32225066 DOI: 10.3390/ijms21072292] [Reference Citation Analysis]
27 De Oliveira Andrade F, Yu W, Zhang X, Carney E, Hu R, Clarke R, FitzGerald K, Hilakivi-Clarke L. Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model. Endocr Relat Cancer 2019;26:339-53. [PMID: 30640711 DOI: 10.1530/ERC-18-0393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Vignoli A, Muraro E, Miolo G, Tenori L, Turano P, Di Gregorio E, Steffan A, Luchinat C, Corona G. Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy. Cancers (Basel) 2020;12:E314. [PMID: 32013102 DOI: 10.3390/cancers12020314] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
29 Jayaganesh R, Pugalendhi P, Murali R. Effect of citronellol on NF-kB inflammatory signaling molecules in chemical carcinogen-induced mammary cancer in the rat model. J Biochem Mol Toxicol 2020;34:e22441. [PMID: 31926054 DOI: 10.1002/jbt.22441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Utz VEM, Perdigón G, de Moreno de LeBlanc A. Milk fermented by Lactobacillus casei CRL431 modifies cytokine profiles associated to different stages of breast cancer development in mice. Benef Microbes 2019;10:689-97. [PMID: 31122044 DOI: 10.3920/BM2019.0011] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Richardson AK, Walker LC, Cox B, Rollag H, Robinson BA, Morrin H, Pearson JF, Potter JD, Paterson M, Surcel HM, Pukkala E, Currie MJ. Breast cancer and cytomegalovirus. Clin Transl Oncol 2020;22:585-602. [PMID: 31256361 DOI: 10.1007/s12094-019-02164-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
32 Cevey ÁC, Penas FN, Alba Soto CD, Mirkin GA, Goren NB. IL-10/STAT3/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole. Front Immunol 2019;10:1267. [PMID: 31214200 DOI: 10.3389/fimmu.2019.01267] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
33 Atiya HI, Dvorkin-Gheva A, Hassell J, Patel S, Parker RL, Hartstone-Rose A, Hodge J, Fan D, Ramsdell AF. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis. Anticancer Res 2019;39:2277-87. [PMID: 31092419 DOI: 10.21873/anticanres.13344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
34 Eiro N, Gonzalez LO, Fraile M, Cid S, Schneider J, Vizoso FJ. Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities. Cancers (Basel) 2019;11:E664. [PMID: 31086100 DOI: 10.3390/cancers11050664] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
35 Hamed Anber N, El-Sebaie AH, Darwish NHE, Mousa SA, Shamaa SS. Prognostic value of some inflammatory markers in patients with lymphoma. Biosci Rep 2019;39:BSR20182174. [PMID: 30814315 DOI: 10.1042/BSR20182174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Matsui M, Kajikuri J, Kito H, Endo K, Hasegawa Y, Murate S, Ohya S. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca 2+ -Activated K + Channel K Ca 3.1 Activation in Human T-Cell Lymphoma HuT-78 Cells. Mol Pharmacol 2019;95:294-302. [DOI: 10.1124/mol.118.114405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Lee CH. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids. Biochemical Pharmacology 2018;158:261-73. [DOI: 10.1016/j.bcp.2018.10.031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
38 Saraiva DP, Jacinto A, Borralho P, Braga S, Cabral MG. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy. Front Immunol 2018;9:2605. [PMID: 30555458 DOI: 10.3389/fimmu.2018.02605] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
39 Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Cook L, Talmadge JE. Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival. Clin Exp Metastasis. 2018;35:797-818. [PMID: 30327985 DOI: 10.1007/s10585-018-9941-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
40 Huang SC, Wei PC, Hwang-Verslues WW, Kuo WH, Jeng YM, Hu CM, Shew JY, Huang CS, Chang KJ, Lee EY, Lee WH. TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB. EMBO Mol Med 2017;9:1660-80. [PMID: 28993429 DOI: 10.15252/emmm.201606914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
41 Sterle HA, Nicoud MB, Massari NA, Táquez Delgado MA, Herrero Ducloux MV, Cremaschi GA, Medina VA. Immunomodulatory role of histamine H4 receptor in breast cancer. Br J Cancer 2019;120:128-38. [PMID: 29988113 DOI: 10.1038/s41416-018-0173-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
42 Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S. A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease. Cancer Manag Res 2018;10:1749-61. [PMID: 29983594 DOI: 10.2147/CMAR.S160452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
43 Chagas BS, Lima RCP, Paiva Júnior SSL, Silva RCO, Cordeiro MN, Silva Neto JDC, Batista MVA, Silva AJD, Gurgel APAD, Freitas AC. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus. Cytokine 2019;113:99-104. [PMID: 29935877 DOI: 10.1016/j.cyto.2018.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Mendes LO, Castilho ACS, Pinho CF, Gonçalvez BF, Razza EM, Chuffa LGA, Anselmo-franci JA, Scarano WR, Martinez FE. Modulation of inflammatory and hormonal parameters in response to testosterone therapy: Effects on the ventral prostate of adult rats: Testosterone modulates inflammatory response. Cell Biol Int 2018;42:1200-11. [DOI: 10.1002/cbin.10990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Matsumoto M, Flores EM, Kimachi PP, Gouveia FV, Kuroki MA, Barros ACSD, Sampaio MMC, Andrade FEM, Valverde J, Abrantes EF, Simões CM, Pagano RL, Martinez RCR. Benefits in radical mastectomy protocol: a randomized trial evaluating the use of regional anesthesia. Sci Rep 2018;8:7815. [PMID: 29777144 DOI: 10.1038/s41598-018-26273-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
46 Gregório AC, Lacerda M, Figueiredo P, Simões S, Dias S, Moreira JN. Meeting the needs of breast cancer: A nucleolin’s perspective. Critical Reviews in Oncology/Hematology 2018;125:89-101. [DOI: 10.1016/j.critrevonc.2018.03.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
47 Lv Z, Liu M, Shen J, Xiang D, Ma Y, Ji Y. Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases. Exp Ther Med 2018;15:5475-80. [PMID: 29904427 DOI: 10.3892/etm.2018.6109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Alotaibi MR, Hassan ZK, Al-Rejaie SS, Alshammari MA, Almutairi MM, Alhoshani AR, Alanazi WA, Hafez MM, Al-Shabanah OA. Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing. Asian Pac J Cancer Prev 2018;19:777-83. [PMID: 29582634 DOI: 10.22034/APJCP.2018.19.3.777] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
49 Budna J, Kaczmarek M, Kolecka-Bednarczyk A, Spychalski Ł, Zawierucha P, Goździk-Spychalska J, Nowicki M, Batura-Gabryel H, Sikora J. Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions. J Immunol Res 2018;2018:9876014. [PMID: 29785404 DOI: 10.1155/2018/9876014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
50 Llopiz D, Ruiz M, Infante S, Villanueva L, Silva L, Hervas-Stubbs S, Alignani D, Guruceaga E, Lasarte JJ, Sarobe P. IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget 2017;8:2659-71. [PMID: 27926522 DOI: 10.18632/oncotarget.13736] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
51 Jiang Y, Yang M, Sun X, Chen X, Ma M, Yin X, Qian S, Zhang Z, Fu Y, Liu J, Han X, Xu J, Shang H. IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection. BMC Infect Dis 2018;18:80. [PMID: 29439673 DOI: 10.1186/s12879-018-2991-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
52 Liu C, Wang Q, Sun B, Meng X, Li L, Yang L, Cong Y, Liu J, Xuan L, Huang Y, Wu S. Low BMI is correlated with increased TGF-β and IL-10 mRNA levels in the peripheral blood of breast cancer patients. IUBMB Life 2018;70:237-45. [PMID: 29405562 DOI: 10.1002/iub.1721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
53 Todorović-raković N, Radulovic M, Vujasinović T, Milovanović J, Nikolić-vukosavljević D. The time-dependent prognostic value of intratumoral cytokine expression profiles in a natural course of primary breast cancer with a long-term follow-up. Cytokine 2018;102:12-7. [DOI: 10.1016/j.cyto.2017.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Mahlbacher G, Curtis LT, Lowengrub J, Frieboes HB. Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment. J Immunother Cancer 2018;6:10. [PMID: 29382395 DOI: 10.1186/s40425-017-0313-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
55 Martínez-Chacón G, Brown KA, Docanto MM, Kumar H, Salminen S, Saarinen N, Mäkelä S. IL-10 suppresses TNF-α-induced expression of human aromatase gene in mammary adipose tissue. FASEB J 2018;32:3361-70. [PMID: 29401621 DOI: 10.1096/fj.201700938RRR] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
56 Mohamed HT, El-Husseiny N, El-Ghonaimy EA, Ibrahim SA, Bazzi ZA, Cavallo-Medved D, Boffa MB, El-Shinawi M, Mohamed MM. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages. Curr Probl Cancer 2018;42:215-30. [PMID: 29459177 DOI: 10.1016/j.currproblcancer.2018.01.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
57 Muraro E, Furlan C, Avanzo M, Martorelli D, Comaro E, Rizzo A, Fae' DA, Berretta M, Militello L, Del Conte A, Spazzapan S, Dolcetti R, Trovo' M. Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer. Front Immunol 2017;8:1476. [PMID: 29163540 DOI: 10.3389/fimmu.2017.01476] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
58 Hanna M, Dumas I, Orain M, Jacob S, Têtu B, Sanschagrin F, Bureau A, Poirier B, Diorio C. Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients. PLoS One 2017;12:e0183579. [PMID: 28846716 DOI: 10.1371/journal.pone.0183579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
59 Autenshlyus A, Arkhipov S, Mikhailova E, Marinkin I, Arkhipova V, Mogilnaya E, Varaksin N, Rukavishnikov M. Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes. Int J Immunopathol Pharmacol 2017;30:308-14. [PMID: 28745079 DOI: 10.1177/0394632017720055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
60 Sabet S, El-sayed SK, Mohamed HT, El-shinawi M, Mohamed MM. Inflammatory breast cancer: High incidence of GCC haplotypes (−1082A/G, −819T/C, and −592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients’ carcinoma tissues. Tumour Biol 2017;39:101042831771339. [DOI: 10.1177/1010428317713393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Thabet NM, Moustafa EM. Synergistic effect of Ebselen and gamma radiation on breast cancer cells. Int J Radiat Biol 2017;93:784-92. [PMID: 28463038 DOI: 10.1080/09553002.2017.1325024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
62 Ahmed S, Othman NH. The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: an experimental animal study. BMC Complement Altern Med 2017;17:208. [PMID: 28399853 DOI: 10.1186/s12906-017-1721-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
63 Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y. Mechanism of immune evasion in breast cancer. Onco Targets Ther 2017;10:1561-73. [PMID: 28352189 DOI: 10.2147/OTT.S126424] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
64 Li X, Lu P, Li B, Zhang W, Yang R, Chu Y, Luo K. Interleukin 2 and interleukin 10 function synergistically to promote CD8+ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Int J Biochem Cell Biol 2017;87:1-7. [PMID: 28274688 DOI: 10.1016/j.biocel.2017.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
65 Regier MC, Montanez-Sauri SI, Schwartz MP, Murphy WL, Beebe DJ, Sung KE. The Influence of Biomaterials on Cytokine Production in 3D Cultures. Biomacromolecules 2017;18:709-18. [PMID: 28157290 DOI: 10.1021/acs.biomac.6b01469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
66 Mehta AM, Mooij M, Branković I, Ouburg S, Morré SA, Jordanova ES. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review. J Immunol Res 2017;2017:8913860. [PMID: 28280748 DOI: 10.1155/2017/8913860] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
67 Farmaki E, Kaza V, Papavassiliou AG, Chatzistamou I, Kiaris H. Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3. Cancer Lett 2017;389:49-58. [PMID: 28041977 DOI: 10.1016/j.canlet.2016.12.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
68 Lee SH, Park SW. [Inflammation and Cancer Development in Pancreatic and Biliary Tract Cancer]. Korean J Gastroenterol 2015;66:325-39. [PMID: 26691190 DOI: 10.4166/kjg.2015.66.6.325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Larouche D, Hanna M, Chang SL, Jacob S, Têtu B, Diorio C. Evaluation of Antioxidant Intakes in Relation to Inflammatory Markers Expression Within the Normal Breast Tissue of Breast Cancer Patients. Integr Cancer Ther 2017;16:485-95. [PMID: 27903840 DOI: 10.1177/1534735416676584] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
70 Sghaier I, Mouelhi L, Rabia NA, Alsaleh BR, Ghazoueni E, Almawi WY, Loueslati BY. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine. 2017;89:62-67. [PMID: 28340949 DOI: 10.1016/j.cyto.2016.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
71 R, Agnihotri N, Singh AP, Bhatnagar A. Involvement of Regulatory T Cells and Their Cytokines Repertoire in Chemopreventive Action of Fish Oil in Experimental Colon Cancer. Nutrition and Cancer 2016;68:1181-91. [DOI: 10.1080/01635581.2016.1212245] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
72 Vangan N, Cao Y, Jia X, Bao W, Wang Y, He Q, Binderiya U, Feng X, Li T, Hao H, Wang Z. mTORC1 mediates peptidoglycan induced inflammatory cytokines expression and NF-κB activation in macrophages. Microb Pathog 2016;99:111-8. [PMID: 27524262 DOI: 10.1016/j.micpath.2016.08.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
73 Conroy SM, Courneya KS, Brenner DR, Shaw E, O'Reilly R, Yasui Y, Woolcott CG, Friedenreich CM. Impact of aerobic exercise on levels of IL-4 and IL-10: results from two randomized intervention trials. Cancer Med 2016;5:2385-97. [PMID: 27485297 DOI: 10.1002/cam4.836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
74 Fernandez-Garcia B, Eiro N, Miranda MA, Cid S, González LO, Domínguez F, Vizoso FJ. Prognostic significance of inflammatory factors expression by stroma from breast carcinomas. Carcinogenesis 2016;37:768-76. [PMID: 27207649 DOI: 10.1093/carcin/bgw062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
75 Gray MJ, Gong J, Hatch MM, Nguyen V, Hughes CC, Hutchins JT, Freimark BD. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers. Breast Cancer Res 2016;18:50. [PMID: 27169467 DOI: 10.1186/s13058-016-0708-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
76 Reed RG, Weihs KL, Sbarra DA, Breen EC, Irwin MR, Butler EA. Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis. Brain Behav Immun 2016;56:165-74. [PMID: 26916219 DOI: 10.1016/j.bbi.2016.02.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
77 Bhattacharjee HK, Bansal VK, Nepal B, Srivastava S, Dinda AK, Misra MC. Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis? Indian J Surg Oncol 2016;7:320-5. [PMID: 27651693 DOI: 10.1007/s13193-016-0512-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
78 Martins GR, Gelaleti GB, Moschetta MG, Maschio-Signorini LB, Zuccari DA. Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors. Mediators Inflamm 2016;2016:9512743. [PMID: 26989335 DOI: 10.1155/2016/9512743] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
79 Vishwakarma P, Parmar N, Yadav PK, Chandrakar P, Kar S. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis. J Mol Med (Berl) 2016;94:695-710. [PMID: 26830627 DOI: 10.1007/s00109-016-1384-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
80 Negi AK, Renuka, Bhatnagar A, Agnihotri N. Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer. Inflammopharmacology 2016;24:11-22. [PMID: 26749133 DOI: 10.1007/s10787-015-0259-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
81 Zhao S, Wu D, Wu P, Wang Z, Huang J. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS One. 2015;10:e0139598. [PMID: 26440936 DOI: 10.1371/journal.pone.0139598] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
82 Ernst B, Anderson KS. Immunotherapy for the treatment of breast cancer. Curr Oncol Rep. 2015;17:5. [PMID: 25677118 DOI: 10.1007/s11912-014-0426-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
83 Ostapchuk YO, Cetin EA, Perfilyeva YV, Yilmaz A, Skiba YA, Chirkin AP, Omarbaeva NA, Talaeva SG, Belyaev NN, Deniz G. Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-β in healthy donors and breast cancer patients. Cell Immunol 2015;298:37-46. [PMID: 26362675 DOI: 10.1016/j.cellimm.2015.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
84 Yeap SK, Abu N, Mohamad NE, Beh BK, Ho WY, Ebrahimi S, Yusof HM, Ky H, Tan SW, Alitheen NB. Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice. BMC Complement Altern Med 2015;15:306. [PMID: 26335427 DOI: 10.1186/s12906-015-0832-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
85 Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R. Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients. BMC Cancer 2014;14:954. [PMID: 25512030 DOI: 10.1186/1471-2407-14-954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
86 Rossowska J, Anger N, Kicielińska J, Pajtasz-Piasecka E, Bielawska-Pohl A, Wojas-Turek J, Duś D. Temporary elimination of IL-10 enhanced the effectiveness of cyclophosphamide and BMDC-based therapy by decrease of the suppressor activity of MDSCs and activation of antitumour immune response. Immunobiology 2015;220:389-98. [PMID: 25454807 DOI: 10.1016/j.imbio.2014.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
87 Hu D, Wan L, Chen M, Caudle Y, LeSage G, Li Q, Yin D. Essential role of IL-10/STAT3 in chronic stress-induced immune suppression. Brain Behav Immun 2014;36:118-27. [PMID: 24513872 DOI: 10.1016/j.bbi.2013.10.016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
88 Jiang X. Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B. 2014;15:1-15. [PMID: 24390741 DOI: 10.1631/jzus.b1300264] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
89 Li Y, Gao P, Yang J, Yu H, Zhu Y, Si W. Relationship between IL-10 expression and prognosis in patients with primary breast cancer. Tumour Biol 2014;35:11533-40. [PMID: 25129439 DOI: 10.1007/s13277-014-2249-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
90 E Lyon D, Mohanraj L, Kelly DL, Elswick R Jr. Health Promoting Life-Style Behaviors and Systemic Inflamma-tion in African American and Caucasian Women Prior to Chemo-therapy for Breast Cancer. Health Promot Perspect 2014;4:18-26. [PMID: 25097833 DOI: 10.5681/hpp.2014.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
91 Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J. The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res 2015;35:1-16. [PMID: 25068787 DOI: 10.1089/jir.2014.0026] [Cited by in Crossref: 214] [Cited by in F6Publishing: 196] [Article Influence: 26.8] [Reference Citation Analysis]
92 Mendes LO, Scarano WR, Rochel-maia SS, Fioruci-fontaneli BA, Chuffa LGA, Martinez FE. Testosterone Therapy Differently Regulates the Anti- and Pro-Inflammatory Cytokines in the Plasma and Prostate of Rats Submitted to Chronic Ethanol Consumption (UChB). Am J Reprod Immunol 2014;72:317-25. [DOI: 10.1111/aji.12268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
93 Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. [PMID: 24901008 DOI: 10.1155/2014/149185] [Cited by in Crossref: 715] [Cited by in F6Publishing: 748] [Article Influence: 89.4] [Reference Citation Analysis]
94 Mohamed MM, El-ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-shinawi M. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. The International Journal of Biochemistry & Cell Biology 2014;46:138-47. [DOI: 10.1016/j.biocel.2013.11.015] [Reference Citation Analysis]
95 Mohamed MM, El-Ghonaimy EA, Nouh MA, Schneider RJ, Sloane BF, El-Shinawi M. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int J Biochem Cell Biol. 2014;46:138-147. [PMID: 24291763 DOI: 10.1016/j.biocel.2013.11.015] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
96 Alibek K, Kakpenova A, Mussabekova A, Sypabekova M, Karatayeva N. Role of viruses in the development of breast cancer. Infect Agent Cancer 2013;8:32. [PMID: 24138789 DOI: 10.1186/1750-9378-8-32] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
97 Azzi S, Hebda JK, Gavard J. Vascular permeability and drug delivery in cancers. Front Oncol 2013;3:211. [PMID: 23967403 DOI: 10.3389/fonc.2013.00211] [Cited by in Crossref: 152] [Cited by in F6Publishing: 144] [Article Influence: 16.9] [Reference Citation Analysis]
98 Jiang X, Shapiro DJ. The immune system and inflammation in breast cancer. Mol Cell Endocrinol 2014;382:673-82. [PMID: 23791814 DOI: 10.1016/j.mce.2013.06.003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 13.4] [Reference Citation Analysis]
99 Kalli F, Machiorlatti R, Battaglia F, Parodi A, Conteduca G, Ferrera F, Proietti M, Tardito S, Sanguineti M, Millo E, Fenoglio D, De Palma R, Inghirami G, Filaci G. Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice. J Transl Med 2013;11:120. [PMID: 23663506 DOI: 10.1186/1479-5876-11-120] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
100 Newman G, Gonzalez-Perez RR. Leptin-cytokine crosstalk in breast cancer. Mol Cell Endocrinol 2014;382:570-82. [PMID: 23562747 DOI: 10.1016/j.mce.2013.03.025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
101 Ursini-Siegel J. Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies? Front Oncol 2013;3:23. [PMID: 23408142 DOI: 10.3389/fonc.2013.00023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Kumar A, Singh SM. Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules. Mol Cell Biochem 2012;371:43-54. [DOI: 10.1007/s11010-012-1421-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]